Paper6794841
The six disease of WHO.
Waters MF. Br Med J (Clin Res Ed), 1981. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. The six disease of WHO. Papers, record 6794841. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6794841
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leprosy | Major topic |
| Adult | |
| Animals | |
| Dapsone | |
| Drug Administration Schedule | |
| Drug Resistance, Microbial | |
| Humans | |
| Mycobacterium leprae | |
| Rifampin | |
| Time Factors |
Source PubMed
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14492126 | A classification of leprosy for research purposes. | Lepr Rev | 1962 | https://conductscience.org/library/papers/14492126 | PubMed |
| 2 | 392212 | Dapsone-resistant leprosy in Ethiopia. | Lepr Rev | 1979 | https://conductscience.org/library/papers/392212 | PubMed |
| 3 | 14445823 | Acid-fast bacilli in nasal excretions in leprosy, and results of inoculation of mice. | Am J Hyg | 1960 | https://conductscience.org/library/papers/14445823 | PubMed |
| 4 | 5950347 | Classification of leprosy according to immunity. A five-group system. | Int J Lepr Other Mycobact Dis | 1966 | https://conductscience.org/library/papers/5950347 | PubMed |
| 5 | 4860661 | Experimental lepromatous leprosy. | Nature | 1967 | https://conductscience.org/library/papers/4860661 | PubMed |
| 6 | 4877714 | The death of Mycobacterium leprae during treatment with 4,4'-diaminodiphenylsulfone (DDS). Initial rate in patients. | Am J Trop Med Hyg | 1968 | https://conductscience.org/library/papers/4877714 | PubMed |
| 7 | 4903972 | Experimental and clinical studies on rifampicin in treatment of leprosy. | Br Med J | 1970 | https://conductscience.org/library/papers/4903972 | PubMed |
| 8 | 4945738 | Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes. | Clin Exp Immunol | 1971 | https://conductscience.org/library/papers/4945738 | PubMed |
| 9 | 4554496 | Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae. | Am J Trop Med Hyg | 1972 | https://conductscience.org/library/papers/4554496 | PubMed |
| 10 | 4948218 | Attempts to establish the armadillo (Dasypus novemcinctus Linn.) as a model for the study of leprosy. I. Report of lepromatoid leprosy in an experimentally infected armadillo. | Int J Lepr Other Mycobact Dis | 1971 | https://conductscience.org/library/papers/4948218 | PubMed |
| 11 | 4559066 | Rapid bactericidal effect of rifampin on Mycobacterium leprae. | Am J Trop Med Hyg | 1972 | https://conductscience.org/library/papers/4559066 | PubMed |
| 12 | 4613977 | Ten years of dapsone in lepromatous leprosy: clinical, bacteriological and histological assessment and the finding of viable leprosy bacilli. | Lepr Rev | 1974 | https://conductscience.org/library/papers/4613977 | PubMed |
| 13 | 49662 | Sulphone resistance in leprosy. A review of one hundred proven clinical cases. | Lancet | 1975 | https://conductscience.org/library/papers/49662 | PubMed |
| 14 | 776852 | Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies. | Int J Lepr Other Mycobact Dis | 1976 | https://conductscience.org/library/papers/776852 | PubMed |
| 15 | 959886 | Leprosy in the United States, 1950-1969: an epidemiologic review. | South Med J | 1976 | https://conductscience.org/library/papers/959886 | PubMed |
| 16 | 63780 | Rifampin-resistant leprosy. | Lancet | 1976 | https://conductscience.org/library/papers/63780 | PubMed |
| 17 | 339995 | Rifampicin for lepromatous leprosy: nine years' experience. | Br Med J | 1978 | https://conductscience.org/library/papers/339995 | PubMed |
| 18 | 14188912 | SULPHONE RESISTANCE IN LEPROSY. AN EXPERIMENTAL AND CLINICAL STUDY. | Lancet | 1964 | https://conductscience.org/library/papers/14188912 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 36684586 | SARS-CoV-2 Spike protein activates TMEM16F-mediated platelet procoagulant activity. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/36684586 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6794841
GET https://conductscience.org/api/papers/v1/6794841/authors